表紙
市場調查報告書
商品編碼
1028899

生物相似藥荷爾蒙的全球市場 (2021年) - COVID-19造成的成長和變化 (2030年)

Biosimilar Hormones Global Market Report 2021: COVID-19 Growth And Change To 2030

出版日期: 按訂單生產 | 出版商: The Business Research Company | 英文 175 Pages | 商品交期: 2-10個工作天內

價格
  • 全貌
  • 簡介
  • 目錄
簡介

本報告提供全球生物相似藥荷爾蒙市場相關調查分析,提供市場特徵,市場規模與成長率,市場區隔,各地區·各國明細,競爭情形,市場佔有率,趨勢與策略相關的系統性資訊。

目錄

第1章 摘要整理

第2章 生物相似藥荷爾蒙市場特徵

第3章 生物相似藥荷爾蒙市場趨勢與策略

第4章 COVID-19對生物相似藥荷爾蒙的影響

第5章 生物相似藥荷爾蒙的市場規模與成長率

  • 全球生物相似藥荷爾蒙市場實際成果 (金額)
  • 全球生物相似藥荷爾蒙市場預測 (金額)

第6章 生物相似藥荷爾蒙市場區隔

  • 全球生物相似藥荷爾蒙市場:各類型,實際成果與預測 (金額)
  • Teriparatide生物相似藥
  • 促濾泡素Alpha生物相似藥
  • 胰島素生物相似藥
  • 生長激素生物相似藥
  • 其他
  • 全球生物相似藥荷爾蒙市場:各用途,實際成果與預測 (金額)
  • 研究·生物科技
  • 診斷
  • 生物催化劑
  • 治療
  • 其他
  • 全球生物相似藥荷爾蒙市場:各流通管道,實際成果與預測 (金額)
  • 醫院·零售藥局
  • 線上藥局/網路藥局
  • 專門診所

第7章 生物相似藥市場各地區·各國分析

  • 全球生物相似藥荷爾蒙市場:各地區,實際成果與預測 (金額)
  • 全球生物相似藥荷爾蒙市場:各國,實際成果與預測 (金額)

第8章 亞太地區的生物相似藥荷爾蒙市場

  • 亞太地區的生物相似藥荷爾蒙市場概要
  • 地區資訊,COVID-19的影響,市場資訊,背景資訊,政府的積極推動,法規,法規機關,主要的協會,課稅,公司稅結構,投資,主要企業
  • 亞太地區的生物相似藥荷爾蒙市場:各類型,實際成果與預測 (金額)

第9章 中國的生物相似藥荷爾蒙市場

  • 中國的生物相似藥市場概要
  • 中國的生物相似藥荷爾蒙市場:各類型,實際成果與預測 (金額)

第10章 印度的生物相似藥荷爾蒙市場

  • 印度的生物相似藥荷爾蒙市場:各類型,實際成果與預測 (金額)

第11章 日本的生物相似藥荷爾蒙市場

  • 日本的生物相似藥荷爾蒙市場:各類型,實際成果與預測 (金額)

第12章 澳洲的生物相似藥荷爾蒙市場

  • 澳洲的生物相似藥荷爾蒙市場:各類型,實際成果與預測 (金額)

第13章 印尼的生物相似藥荷爾蒙市場

  • 印尼的生物相似藥荷爾蒙市場:各類型,實際成果與預測 (金額)

第14章 韓國的生物相似藥荷爾蒙市場

  • 韓國的生物相似藥荷爾蒙市場:各類型,實際成果與預測 (金額)

第15章 西歐的生物相似藥荷爾蒙市場

  • 西歐的生物相似藥荷爾蒙市場概要
  • 西歐的生物相似藥荷爾蒙市場:各類型,實際成果與預測 (金額)

第16章 英國的生物相似藥荷爾蒙市場

  • 英國的生物相似藥荷爾蒙市場:各類型,實際成果與預測 (金額)

第17章 德國的生物相似藥荷爾蒙市場

  • 德國的生物相似藥荷爾蒙市場:各類型,實際成果與預測 (金額)

第18章 法國的生物相似藥荷爾蒙市場

  • 法國的生物相似藥荷爾蒙市場:各類型,實際成果與預測 (金額)

第19章 東歐的生物相似藥荷爾蒙市場

  • 東歐的生物相似藥荷爾蒙市場概要
  • 東歐的生物相似藥荷爾蒙市場:各類型,實際成果與預測 (金額)

第20章 俄羅斯的生物相似藥荷爾蒙市場

  • 俄羅斯的生物相似藥荷爾蒙市場:各類型,實際成果與預測 (金額)

第21章 北美的生物相似藥荷爾蒙市場

  • 北美的生物相似藥荷爾蒙市場概要
  • 北美的生物相似藥荷爾蒙市場:各類型,實際成果與預測 (金額)

第22章 美國的生物相似藥荷爾蒙市場

  • 美國的生物相似藥荷爾蒙市場概要
  • 美國的生物相似藥荷爾蒙市場:各類型,實際成果與預測 (金額)

第23章 南美的生物相似藥荷爾蒙市場

  • 南美的生物相似藥荷爾蒙市場概要
  • 南美的生物相似藥荷爾蒙市場:各類型,實際成果與預測 (金額)

第24章 巴西的生物相似藥荷爾蒙市場

  • 巴西的生物相似藥荷爾蒙市場:各類型,實際成果與預測 (金額)

第25章 中東的生物相似藥荷爾蒙市場

  • 中東的生物相似藥荷爾蒙市場概要
  • 中東的生物相似藥荷爾蒙市場:各類型,實際成果與預測 (金額)

第26章 非洲的生物相似藥荷爾蒙市場

  • 非洲的生物相似藥荷爾蒙市場概要
  • 非洲的生物相似藥荷爾蒙市場:各類型,實際成果與預測 (金額)

第27章 生物相似藥市場競爭情形和企業簡介

  • 生物相似藥荷爾蒙市場競爭情形
  • 生物相似藥荷爾蒙市場企業簡介
    • Teva Pharmaceutical
    • Gedeon Richter
    • Intas Pharmaceuticals
    • Biocon
    • Mylan

第28章 生物相似藥荷爾蒙的開發平台分析

第29章 生物相似藥荷爾蒙市場上主要的收購與合併

第30章 生物相似藥市場未來發展預測與潛在性分析

第31章 附錄

目錄
Product Code: h923

Biosimilar Hormones Global Market Report 2021: COVID-19 Growth And Change to 2030 from The Business Research Company provides the strategists, marketers and senior management with the critical information they need to assess the global biosimilar hormones market.

This report focuses on biosimilar hormones market which is experiencing strong growth. The report gives a guide to the biosimilar hormones market which will be shaping and changing our lives over the next ten years and beyond, including the markets response to the challenge of the global pandemic.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 12+ geographies.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order.

Where is the largest and fastest growing market for the biosimilar hormones? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The Biosimilar hormones market global report from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography. It places the market within the context of the wider biosimilar hormones market, and compares it with other markets.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, the influence of the COVID-19 virus and forecasting its growth.
  • Market segmentations break down market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
  • The biosimilar hormones market section of the report gives context. It compares the biosimilar hormones market with other segments of the biosimilar hormones market by size and growth, historic and forecast. It analyses GDP proportion, expenditure per capita, biosimilar hormones indicators comparison.

Scope

Markets Covered: 1) By Type: Teriparatide Biosimilars; Follitropin Alfa Biosimilars; Insulin Biosimilars; Somatropin Biosimilars; Others

2) By Application: Research & Biotechnology; Diagnostics; Biocatalysts; Therapeutics; Others

3) By Distribution Channel: Hospital And Retail Pharmacy; Online Pharmacy/epharmacy; Speciality Clinics

Companies Mentioned: Teva Pharmaceutical; Gedeon Richter; Intas Pharmaceuticals; Biocon; Mylan

Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Table of Contents

1. Executive Summary

2. Biosimilar Hormones Market Characteristics

3. Biosimilar Hormones Market Trends And Strategies

4. Impact Of COVID-19 On Biosimilar Hormones

5. Biosimilar Hormones Market Size And Growth

  • 5.1. Global Biosimilar Hormones Historic Market, 2015-2020, $ Billion
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints On The Market
  • 5.2. Global Biosimilar Hormones Forecast Market, 2020-2025F, 2030F, $ Billion
    • 5.2.1. Drivers Of The Market
    • 5.2.2. Restraints On the Market

6. Biosimilar Hormones Market Segmentation

  • 6.1. Global Biosimilar Hormones Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Teriparatide Biosimilars
  • Follitropin Alfa Biosimilars
  • Insulin Biosimilars
  • Somatropin Biosimilars
  • Others
  • 6.2. Global Biosimilar Hormones Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Research & biotechnology
  • Diagnostics
  • Biocatalysts
  • Therapeutics
  • Others
  • 6.3. Global Biosimilar Hormones Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Hospital and Retail Pharmacy
  • Online Pharmacy/ePharmacy
  • Speciality Clinics

7. Biosimilar Hormones Market Regional And Country Analysis

  • 7.1. Global Biosimilar Hormones Market, Split By Region, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 7.2. Global Biosimilar Hormones Market, Split By Country, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

8. Asia-Pacific Biosimilar Hormones Market

  • 8.1. Asia-Pacific Biosimilar Hormones Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Biosimilar Hormones Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

9. China Biosimilar Hormones Market

  • 9.1. China Biosimilar Hormones Market Overview
  • 9.2. China Biosimilar Hormones Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F,$ Billion

10. India Biosimilar Hormones Market

  • 10.1. India Biosimilar Hormones Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

11. Japan Biosimilar Hormones Market

  • 11.1. Japan Biosimilar Hormones Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

12. Australia Biosimilar Hormones Market

  • 12.1. Australia Biosimilar Hormones Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

13. Indonesia Biosimilar Hormones Market

  • 13.1. Indonesia Biosimilar Hormones Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

14. South Korea Biosimilar Hormones Market

  • 14.1. South Korea Biosimilar Hormones Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

15. Western Europe Biosimilar Hormones Market

  • 15.1. Western Europe Biosimilar Hormones Market Overview
  • 15.2. Western Europe Biosimilar Hormones Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

16. UK Biosimilar Hormones Market

  • 16.1. UK Biosimilar Hormones Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

17. Germany Biosimilar Hormones Market

  • 17.1. Germany Biosimilar Hormones Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

18. France Biosimilar Hormones Market

  • 18.3. France Biosimilar Hormones Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

19. Eastern Europe Biosimilar Hormones Market

  • 19.1. Eastern Europe Biosimilar Hormones Market Overview
  • 19.2. Eastern Europe Biosimilar Hormones Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

20. Russia Biosimilar Hormones Market

  • 20.1. Russia Biosimilar Hormones Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

21. North America Biosimilar Hormones Market

  • 21.1. North America Biosimilar Hormones Market Overview
  • 21.2. North America Biosimilar Hormones Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

22. USA Biosimilar Hormones Market

  • 22.1. USA Biosimilar Hormones Market Overview
  • 22.2. USA Biosimilar Hormones Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

23. South America Biosimilar Hormones Market

  • 23.1. South America Biosimilar Hormones Market Overview
  • 23.2. South America Biosimilar Hormones Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

24. Brazil Biosimilar Hormones Market

  • 24.1. Brazil Biosimilar Hormones Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

25. Middle East Biosimilar Hormones Market

  • 25.1. Middle East Biosimilar Hormones Market Overview
  • 25.2. Middle East Biosimilar Hormones Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

26. Africa Biosimilar Hormones Market

  • 26.1. Africa Biosimilar Hormones Market Overview
  • 26.2. Africa Biosimilar Hormones Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

27. Biosimilar Hormones Market Competitive Landscape And Company Profiles

  • 27.1. Biosimilar Hormones Market Competitive Landscape
  • 27.2. Biosimilar Hormones Market Company Profiles
    • 27.2.1. Teva Pharmaceutical
      • 27.2.1.1. Overview
      • 27.2.1.2. Products and Services
      • 27.2.1.3. Strategy
      • 27.2.1.4. Financial Performance
    • 27.2.2. Gedeon Richter
      • 27.2.2.1. Overview
      • 27.2.2.2. Products and Services
      • 27.2.2.3. Strategy
      • 27.2.2.4. Financial Performance
    • 27.2.3. Intas Pharmaceuticals
      • 27.2.3.1. Overview
      • 27.2.3.2. Products and Services
      • 27.2.3.3. Strategy
      • 27.2.3.4. Financial Performance
    • 27.2.4. Biocon
      • 27.2.4.1. Overview
      • 27.2.4.2. Products and Services
      • 27.2.4.3. Strategy
      • 27.2.4.4. Financial Performance
    • 27.2.5. Mylan
      • 27.2.5.1. Overview
      • 27.2.5.2. Products and Services
      • 27.2.5.3. Strategy
      • 27.2.5.4. Financial Performance

28. Biosimilar Hormones Pipeline Analysis

29. Key Mergers And Acquisitions In The Biosimilar Hormones Market

30. Biosimilar Hormones Market Future Outlook and Potential Analysis

31. Appendix

  • 31.1. Abbreviations
  • 31.2. Currencies
  • 31.3. Research Inquiries
  • 31.4. The Business Research Company
  • 31.5. Copyright And Disclaimer